Description
Product Overview
CGR-1 5mg is a synthetic peptide analogue designed for research into amylin and calcitonin receptor biology. It consists of a linear amino acid chain modified to enhance receptor selectivity and molecular stability, allowing for detailed investigation of its biochemical characteristics and receptor-binding dynamics. This peptide serves as a model compound in studies focusing on peptide–receptor interactions, metabolic signaling, and the molecular mechanisms governing satiety and glucose regulation.
Chemical Characteristics
The compound features an engineered amino acid sequence with structural modifications that improve peptide resistance to enzymatic degradation and prolong biological half-life in controlled environments. It is provided in a lyophilized powder form with a unit size of 5 mg per vial and may be reconstituted for use in in vitro research. The sequence is specifically designed to mimic endogenous peptide signaling molecules, making it valuable in receptor mapping and pharmacodynamic modeling studies.
Specifications
- Compound: Synthetic amylin analogue (DACRA-type peptide)
- Molecular Type: Peptide chain
- Molecular Weight: Varies by salt form
- Purity: ≥98% (HPLC)
- Form: Lyophilized powder
- Unit Size: 5 mg per vial
- Storage: Keep in a cool, dry environment away from direct light
Intended Use
This material is provided For Research Use Only (RUO). It is not approved for human or veterinary consumption, therapeutic application, or diagnostic testing. Handling and experimentation should be performed solely by qualified personnel within controlled laboratory facilities.
Disclaimer
CGR-1 5mg is intended exclusively for in vitro laboratory research. It has not been evaluated by the FDA or any other regulatory agency. This compound is not designed to diagnose, treat, cure, or prevent any disease. All purchases must be made by qualified researchers or licensed institutions in compliance with applicable regulations.
